imgWayne W. Grody, M.D., Ph.D.
Geneticist and Director of the Diagnostic Molecular Pathology Laboratory

Wayne W. Grody, M.D., Ph.D. is a Professor in the Departments of Pathology & Laboratory Medicine, Pediatrics, and Human Genetics at the UCLA School of Medicine. He is the founder and director of the Diagnostic Molecular Pathology Laboratory within the UCLA Medical Center. In addition, he is heavily involved in basic molecular genetics research involving regulation of gene expression in hereditary diseases and cancer, population molecular genetic screening, and construction of artificial human mutation samples. He has been one of the primary developers of quality assurance and ethical guidelines for DNA- basedgenetic testing for a large number of governmental and professional agencies, including FDA, VA, AMA, CAP, ACMG, ASHG, NCCLS, CDC, NIH-DOE Human Genome Project (ELSI program), and PSRGN. He has published over 170 journal articles, as well as scientific and medical books and book chapters. He did his undergraduate work at Johns Hopkins University, received his M.D. and Ph.D. at Baylor College of Medicine, and completed residency and fellowship training at UCLA. He is double board-certified by the American Board of Pathology (Anatomic and Clinical Pathology, Molecular Genetic Pathology) and the American Board of Medical Genetics (Clinical Genetics, Molecular Genetics, and Biochemical Genetics).

See also: CYTOGENETICS


Recent/Featured Publications:

Gau, C.-L., R.A. Rosenblatt, V. Cerullo, F.D. Lay, A.C. Dow, J. Livesay, N. Brunetti-Pierri, B. Lee, S.D. Cederbaum, W.W. Grody and G. Lipshutz. Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector. Molec. Ther. 2009; 17: 1155-1163.
Rosove, M.H. and W.W. Grody. Should we be applying warfarin pharmacogenetics to clinical practice? No, not now. . Ann. Intern. Med. 2009; 151: 270-273.
Mumenthaler, S.M., H. Yu, S. Tze, S.D. Cederbaum, A.E. Pegg, D.B. Seligson and W.W. Grody. . Differential expression of arginase II in androgen-dependent versus androgen-independent prostate cancer.. Int. J. Oncol. 2008; 32: 357-365.



Regulatory & HIPAA
| Contact Us | FAQ
© 2010 UCLA Department of Pathology & Laboratory Medicine, All Rights Reserved.